AVITA Medical Raises FY2026 Sales Guidance from $86.000M-$89.000M to $92.000M-$94.000M vs $86.850M Est

Benzinga · 22h ago
AVITA Medical (NASDAQ:RCEL) raises FY2026 sales outlook from $86.000 million-$89.000 million to $92.000 million-$94.000 million vs $86.850 million estimate.